Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT00065351 · COMPLETED
Trial details
- NCT number
- NCT00065351
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2006-10-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.